Go Pro
→ One trade you can make to move the needle today (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$9.49
+1.9%		$8.83
$6.82
▼
$23.29
$1.44B0.852.47 million shs1.97 million shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$16.67
+10.3%		$12.35
$8.12
▼
$16.69
$524.30M0.52544,698 shs1.48 million shs
Enovis Corporation stock logo
ENOV
Enovis
$24.25
-8.9%		$24.67
$19.14
▼
$34.28
$1.53B1.341.18 million shs1.76 million shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$37.31
+1.4%		$41.15
$29.06
▼
$55.00
$1.67B0.98861,789 shs529,257 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
0.00%-2.21%-2.82%+33.19%-37.81%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
0.00%+23.65%+16.14%+36.62%+50.95%
Enovis Corporation stock logo
ENOV
Enovis
0.00%-8.66%+3.37%+7.83%-6.34%
Omnicell, Inc. stock logo
OMCL
Omnicell
0.00%+4.07%-18.05%-14.99%+19.40%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$9.49
+1.9%		$8.83
$6.82
▼
$23.29
$1.44B0.852.47 million shs1.97 million shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$16.67
+10.3%		$12.35
$8.12
▼
$16.69
$524.30M0.52544,698 shs1.48 million shs
Enovis Corporation stock logo
ENOV
Enovis
$24.25
-8.9%		$24.67
$19.14
▼
$34.28
$1.53B1.341.18 million shs1.76 million shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$37.31
+1.4%		$41.15
$29.06
▼
$55.00
$1.67B0.98861,789 shs529,257 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
0.00%-2.21%-2.82%+33.19%-37.81%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
0.00%+23.65%+16.14%+36.62%+50.95%
Enovis Corporation stock logo
ENOV
Enovis
0.00%-8.66%+3.37%+7.83%-6.34%
Omnicell, Inc. stock logo
OMCL
Omnicell
0.00%+4.07%-18.05%-14.99%+19.40%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
2.80
Moderate Buy$17.4083.35% Upside
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.57
Moderate Buy$23.1738.97% Upside
Enovis Corporation stock logo
ENOV
Enovis
2.70
Moderate Buy$42.0073.20% Upside
Omnicell, Inc. stock logo
OMCL
Omnicell
2.78
Moderate Buy$57.8655.07% Upside

Current Analyst Ratings Breakdown

Latest DCTH, ENOV, OMCL, and ATEC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
8/7/2026
Enovis Corporation stock logo
ENOV
Enovis
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$30.00
8/7/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$30.00 ➝ $32.00
8/7/2026
Enovis Corporation stock logo
ENOV
Enovis
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$40.00 ➝ $39.00
8/6/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$17.00 ➝ $21.00
8/6/2026
Enovis Corporation stock logo
ENOV
Enovis
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$39.00 ➝ $40.00
8/5/2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$11.00 ➝ $13.00
8/5/2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $16.00
8/5/2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$11.00 ➝ $12.00
8/4/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
8/3/2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 8/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$764.16M1.92N/AN/A$0.08 per share118.63
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$85.23M6.79$0.06 per share289.05$3.15 per share5.29
Enovis Corporation stock logo
ENOV
Enovis
$2.25B0.62$24.49 per share0.99$26.09 per share0.93
Omnicell, Inc. stock logo
OMCL
Omnicell
$1.18B1.43$2.80 per share13.31$27.45 per share1.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$143.36M-$0.71N/A189.80N/A-13.49%-6,752.24%-13.88%10/29/2026 (Estimated)
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.011,511.00N/AN/A0.56%0.46%0.42%N/A
Enovis Corporation stock logo
ENOV
Enovis
-$1.18B-$19.267.947.07N/A-47.96%12.03%4.91%N/A
Omnicell, Inc. stock logo
OMCL
Omnicell
$2.05M$0.8423.9034.871.003.13%5.66%3.57%10/29/2026 (Estimated)

Latest DCTH, ENOV, OMCL, and ATEC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0891$0.07+$0.1591$0.07$26.25 million$29.13 million
8/6/2026Q2 2026
Enovis Corporation stock logo
ENOV
Enovis
$0.8470$0.90+$0.0530-$0.02$581.84 million$582.78 million
8/4/2026Q2 2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$0.07$0.07N/A-$0.16$211.26 million$213.51 million
7/30/2026Q2 2026
Omnicell, Inc. stock logo
OMCL
Omnicell
$0.4675$0.94+$0.4725$0.52$310.21 million$312.21 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
Omnicell, Inc. stock logo
OMCL
Omnicell
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
40.35
1.89
1.07
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
9.83
8.95
Enovis Corporation stock logo
ENOV
Enovis
0.84
1.98
1.00
Omnicell, Inc. stock logo
OMCL
Omnicell
0.13
1.64
1.43

Institutional Ownership

CompanyInstitutional Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
66.35%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
Enovis Corporation stock logo
ENOV
Enovis
98.45%
Omnicell, Inc. stock logo
OMCL
Omnicell
97.70%

Insider Ownership

CompanyInsider Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
13.48%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
Enovis Corporation stock logo
ENOV
Enovis
2.90%
Omnicell, Inc. stock logo
OMCL
Omnicell
2.92%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
700154.45 million133.63 millionOptionable
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.70 million27.98 millionOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,80257.67 million56.00 millionOptionable
Omnicell, Inc. stock logo
OMCL
Omnicell
3,58045.48 million44.15 millionOptionable

Recent News About These Companies

Royal Bank of Canada Sells 78,803 Shares of Omnicell, Inc. $OMCL
August 7 at 4:47 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-royal-bank-of-canada-sells-78803-shares-of-omnicell-inc-omcl-2026-08-07/
First Trust Advisors LP Has $2.85 Million Stake in Omnicell, Inc. $OMCL
August 7 at 4:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-first-trust-advisors-lp-has-285-million-stake-in-omnicell-inc-omcl-2026-08-07/
Piper Sandler Reaffirms Overweight Rating for Omnicell (NASDAQ:OMCL)
August 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30941366
Here's Why Omnicell (OMCL) is a Strong Value Stock
August 4, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2967487/here-s-why-omnicell-omcl-is-a-strong-value-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_value_score-2967487
Omnicell's (OMCL) Overweight Rating Reaffirmed at Piper Sandler
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/omnicells-omcl-overweight-rating-reaffirmed-at-piper-sandler-2026-08-03/
KeyCorp Cuts Omnicell (NASDAQ:OMCL) Price Target to $65.00
August 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30937282
Omnicell, Inc. $OMCL Stake Boosted by Public Employees Retirement System of Ohio
August 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-omnicell-inc-omcl-stake-boosted-by-public-employees-retirement-system-of-ohio-2026-08-02/
Arrowstreet Capital Limited Partnership Has $9.32 Million Stake in Omnicell, Inc. $OMCL
August 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-arrowstreet-capital-limited-partnership-has-932-million-stake-in-omnicell-inc-omcl-2026-08-02/
Renaissance Technologies LLC Increases Stake in Omnicell, Inc. $OMCL
August 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-increases-stake-in-omnicell-inc-omcl-2026-08-01/
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Daiichi Sankyo Company (OtherDSKYF) and GE Healthcare Technologies Inc (GEHC)
July 31, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/GEHC/pressreleases/3575317/analysts-offer-insights-on-healthcare-companies-omnicell-omcl-daiichi-sankyo-company-otherdskyf-and-ge-healthcare-technologies-inc-gehc/
Is Omnicell Inc (OMCL) a Bargain After 4.7% Drop? GF Value Says Undervalued
July 31, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/8996608/is-omnicell-inc-omcl-a-bargain-after-47-drop-gf-value-says-undervalued
Omnicell (NASDAQ:OMCL) Releases Earnings Results, Beats Estimates By $0.47 EPS
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/omnicell-nasdaqomcl-releases-earnings-results-beats-estimates-by-047-eps-2026-07-31/
OMCL Q2 Earnings Call Highlights Titan XT Pipeline Growth
July 31, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2965758/omcl-q2-earnings-call-highlights-titan-xt-pipeline-growth?cid=cs-stocknewsapi-ft-analyst_blog_plus|earnings_call_takeaways-2965758
Omnicell (NASDAQ:OMCL) Given New $65.00 Price Target at KeyCorp
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/omnicell-nasdaqomcl-given-new-6500-price-target-at-keycorp-2026-07-31/
Liontrust Investment Partners LLP Has $7.78 Million Stake in Omnicell, Inc. $OMCL
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-liontrust-investment-partners-llp-has-778-million-stake-in-omnicell-inc-omcl-2026-07-31/
Empowered Funds LLC Boosts Stake in Omnicell, Inc. $OMCL
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-empowered-funds-llc-boosts-stake-in-omnicell-inc-omcl-2026-07-31/
Dimensional Fund Advisors LP Acquires 137,834 Shares of Omnicell, Inc. $OMCL
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-acquires-137834-shares-of-omnicell-inc-omcl-2026-07-31/
Bank of New York Mellon Corp Increases Stock Position in Omnicell, Inc. $OMCL
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-increases-stock-position-in-omnicell-inc-omcl-2026-07-31/
Omnicell: Q2 Earnings Snapshot
July 30, 2026  |  houstonchronicle.comH
Omnicell Q2 Non-GAAP Net Income, Revenue Increase; 2026 Non-GAAP EPS Outlook Lifted
July 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/omnicell-q2-non-gaap-net-112945753.html
Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats on revenue but stock drops on weak guidance
July 30, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/omnicell-s-nasdaqomcl-q2-cy2026-beats-on-revenue-but-stock-drops-on-weak-guidance/ar-AA293SCw

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
A Patriot missile launcher and soldier on an airbase tarmac as an F-35 fighter jet flies overhead at sunset.
RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
By Dan Schmidt | July 26, 2026
Bed Bath & Beyond logo displayed above a store display with a bed, folded towels, and home goods shelves.
Bed Bath & Beyond Renovates: The Neighborhood Blueprint
By Jeffrey Neal Johnson | August 6, 2026
Alphatec stock logo

Alphatec NASDAQ:ATEC

$9.49 +0.18 (+1.93%)
As of 04:00 PM Eastern

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$16.67 +1.56 (+10.32%)
As of 04:00 PM Eastern

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Enovis stock logo

Enovis NYSE:ENOV

$24.25 -2.36 (-8.87%)
As of 03:58 PM Eastern

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Omnicell stock logo

Omnicell NASDAQ:OMCL

$37.31 +0.50 (+1.36%)
As of 04:00 PM Eastern

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas